While meta-analysis has demonstrated increased statistical power and more robust estimations in studies, the application of this commonly accepted methodology to cytometry data has been challenging. Different cytometry studies often involve diverse sets of markers. Moreover, the detected values of the same marker are inconsistent between studies due to different experimental designs and cytometer configurations. As a result, the cell subsets identified by existing auto-gating methods cannot be directly compared across studies. We developed MetaCyto for automated meta-analysis of both flow and mass cytometry (CyTOF) data. By combining clustering methods with a silhouette scanning method, MetaCyto is able to identify commonly labeled cell subsets across studies, thus enabling meta-analysis. Applying MetaCyto across a set of 10 heterogeneous cytometry studies totaling 2926 samples enabled us to identify multiple cell populations exhibiting differences in abundance between White and Asian adults. Software is released to the public through GitHub (github.com/hzc363/MetaCyto).
Main text
Meta-analysis of existing data across different studies offers multiple benefits. The aggregated data allows researchers to test hypotheses with increased statistical power. The involvement of multiple independent studies increases the robustness of conclusions drawn. In addition, the complexity of aggregated data allows researchers to test or generate new hypotheses. These benefits have been shown by many studies in areas such as genomics, cancer biology and clinical research and have led to important new biomedical findings [1] [2] [3] [4] . For example, one study showed the correlation between neoantigen abundance in tumors and patient survival by performing meta-analysis of RNA sequencing data from The Cancer Genome Atlas (TCGA) 5 . In another study, meta-analysis of genome-wide association studies identified novel loci that affect the risk of type 1 diabetes 6 .
With the recent advances in high-throughput cytometry technologies the immune system can be characterized at the single cell level with up to 45 parameters, minimizing the technical limitations and allowing capture of more valuable information from immunology studies 7-9 . Open science initiatives have led to more of this type of research data accessible, and the availability of shared cytometry data, including data from flow cytometry and mass cytometry (CyTOF), is growing exponentially. Notably, the ImmPort database (www.immport.org), a repository for immunology-related research and clinical trials, provides numerous studies with thousands of cytometry datasets 10 . However, meta-analysis of cytometry datasets remains particularly challenging. Different studies use diverse sets of protein markers and fluorophore/isotope combinations. The detected values of the same marker are inconsistent between studies because of different cytometer configurations or operators. In addition, the high dimensionality of cytometry data, especially CyTOF data, makes manual gating based meta-analysis difficult and time-consuming.
Multiple computational methods have been proposed to automate the analysis of cytometry data, such as FlowSOM 11 , FlowMeans 12 and CITRUS 13 . Although they are effective in analyzing data from a single study 14, 15 , several limitations have prevented their use in metaanalysis. First, the results of these methods cannot be directly compared across studies. The cell subsets identified by these methods are usually labeled with anonymous identifiers with no cellspecific annotation, making it impossible to identify common cell populations across different studies. In addition, many clustering methods are sensitive to parameter choices. For example, FlowSOM, FlowMeans and SPADE 16 require users to pre-specify the number of clusters. As a result, extensive parameter tuning and manual inspection are required for every cytometry dataset. In meta-analysis where large numbers of input datasets could be involved, these manual selected choices become a major technical burden.
In this study, we developed MetaCyto to enable automated metaanalysis of cytometry datasets, including data from both conventional flow and CyTOF cytometry data. Using novel computational approaches, MetaCyto accurately identifies common cell populations across studies without parameter tuning requirements. It then applies hierarchical models to robustly estimate the effects of factors of interest, such as age, race or vaccination, on the cell populations using data across all input studies.
To test the utility of MetaCyto, we performed a joint analysis of 10 human immunology cytometry datasets contributed by four different institutions [17] [18] [19] [20] . Altogether, this analysis spanned 2926 peripheral blood mononuclear cells (PBMC) or whole blood samples from 984 healthy subjects, which were acquired using either flow cytometry or CyTOF with a diverse set of markers. Among these 984 subjects, over 90 percent were White or Asian. While it is well known that characteristics of multiple immune system-related diseases, such as HIV 21 , systemic lupus erythematosus 22 and hepatitis C 23 , vary between the two racial groups, the heterogeneity of the immune system among the human population has made studying these differences difficult 24, 25 . We hypothesized that a meta-analysis approach could lead to a better understanding of racial differences in the immune system. Using MetaCyto, we not only confirmed a known racial difference, but also identified new cell types whose frequencies differ between White and Asian.
RESULTS

MetaCyto identifies common cell subsets across studies
Our meta-analysis of cytometry data follows four steps: data aggregation, data pre-processing, identification of common cell subsets across studies, and statistical analysis (Fig. 1a) . The third step, identification of common cell subsets across studies, has been one of the main technical challenges preventing automated metaanalysis. Therefore, while all four steps are automated and covered in the MetaCyto software system and documented in the online methods, here we primarily focus on describing our identification and relating of common cell subsets across studies.
MetaCyto employs two automated pipelines, unsupervised analysis and guided analysis, to identify common cell subsets across studies. The unsupervised analysis pipeline identifies cell subsets in a fully automated way. Cytometry data in each study is first clustered using an existing clustering method (Fig. 1b Top) . FlowSOM 11 was implemented as the default clustering method due to its speed and performance. However, any other clustering method, such as hierarchical clustering or FlowMeans, could be substituted as well. At this stage, clusters are labeled with non-informative labels, such as C1, C2, C3, which cannot be related across studies. For example, C1 in study 1 and C1 in study 2 represent entirely different cell populations.
A threshold is then chosen to bisect the distribution of each marker into positive and negative regions, needed to label each cluster in a biologically meaningful way (Fig. 1b Middle) . The selection of a threshold is easy when a clear bi-modal distribution is present, but becomes challenging in other cases. We implemented a Silhouette scanning method, which bisects each marker at the threshold maximizing the average silhouette, a widely used way of describing the quality of clusters 26 . We compared Silhouette scanning against 8 other bisection methods and found it to be superior ( Supplementary  Fig. 1 ).
Clusters are then labeled for each of the markers based on the following two rules: first, if the marker levels of 95% of cells in the cluster are above or below the threshold, the cluster will be labeled as positive or negative for the marker, respectively. Otherwise, the cluster will not be labeled for the marker. For example in Fig 1b, both C2 and C1 in study 2 will be labeled as CD8+ CD4-; second, if a marker is positive or negative in 95% of all cells, the marker is not used to label any clusters. For example, CD45, which is expressed by all immune cells, will not be used to label any cell clusters in the blood. The two rules are used to reduce redundancy and ensure that only the informative markers are used for labeling.
Next, clusters with the same labels are merged into a square shaped cluster (Fig. 1b Bottom) . In cytometry data with higher dimensions, clusters are hyper-rectangles. Following this stage, common cell subsets across studies can be rigorously identified and annotated. For example, the CD4-CD8+ clusters in both study 1 and study 2 correspond to CD8+ T cells.
The guided analysis pipeline identifies cell subsets using pre-defined cell definitions, thus allowing for the search of specific cell subsets defined by immunologists. After bisecting each marker into positive and negative regions, cells fulfilling the pre-defined cell definitions are identified. For example, the CD3+ CD4+ CD8-(CD4+ T cells) cell subset corresponds to the cells that fall into the CD3+ region, CD4+ region and CD8-region concurrently (Fig. 1c) . Notice that both CD45RA+ and CD45RA-populations are included in the cell subset, because the cell definition does not specify the requirement for CD45RA expression. However, researchers could easily alter the cell definition to CD3+ CD4+ CD8-CD45RA+ to find the CD45RA+ cell subset.
Evaluating the guided analysis pipeline
A successful meta-analysis of cytometry data requires cell populations to be identified accurately from each study. To evaluate if the guided analysis pipeline of MetaCyto can accurately identify cell subsets from a single study, we downloaded a set of PBMC cytometry data (SDY478) from ImmPort, with which the original authors identified 88 cell types. Correspondingly, we specified the 88 cell definitions (Supplementary Table 2 ) based on the author's gating strategy and identified these cell subsets for each cytometry sample using the guided analysis pipeline in MetaCyto.
We compared the proportions of all cell subsets estimated by MetaCyto with the original manual gating results and found that MetaCyto estimations are highly consistent with the manual gating result (Fig.  2a-c) . We compared our estimations to two existing methods, flowDensity 27 and ACDC 28 , which can also identify pre-defined cell populations. Our results suggest that MetaCyto's quantification of both major and rare populations were more accurate than FlowDensity's (Fig. 2d,e) . Although ACDC and MetaCyto results had the same correlation with manual gating, ACDC tended to overestimate the cell abundance ( Supplementary Fig. 2a,b) . In addition, a relatively shorter computational time of MetaCyto (around 3 minutes) compare to ACDC (over 2 hours) makes it advantageous in analyzing a large number of datasets.
Evaluating the unsupervised analysis pipeline
We then tested the performance of the unsupervised analysis pipeline of MetaCyto. In the unsupervised analysis pipeline, cell clusters are first identified by an existing clustering algorithm. The subsets are then labeled using informative markers and are merged into hyper-rectangle clusters based on the labeling result (Fig. 1b) .
To learn how such merge affects the quality of clusters, we evaluated the results of two clustering algorithms, FlowSOM 11 and FlowMeans 12 , with and without the merging step. Multiple studies have been conducted to evaluate the performance of existing clustering method for cytometry data 14, 15 . The most recent (Weber et al. 15 ) compared 15 clustering methods and found FlowSOM generally outperformed other methods after manual tuning.
We downloaded an evaluation dataset, West Nile virus dataset (FlowCAP WNV), used by Weber et al 15 and applied FlowSOM. The clustering result is then labeled and merged. Since FlowSOM requires a pre-specified cluster number (K), we did multiple runs with K ranging from 10 to 90. F-measure is used to evaluate the quality of the clusters. We found that the quality of clusters is comparable before and after merging when K equals to 10. However, the performance of FlowSOM drops when K increases. The subsequent merging step prevented FlowSOM performance to deteriorate (Fig.  2f) . We then looked at the total number of clusters identified before and after merging. As expected, FlowSOM identified the same number of clusters specified by K. However, when running the merging step after FlowSOM, the total number of clusters no longer increases after a certain point (Fig. 2g) . The same results were obtained with FlowMeans 12 (Supplementary Fig. 2c,d ).
To see if such benefit of the merging step only exists in datasets where the intrinsic number of cell subsets is small, we applied the same methodology in the normal donor (ND) dataset from FlowCAP competition 14 , where more cell subsets can be identified. Consistent with results from WNV dataset, the merging step is able to prevent the over-partitioning in the ND dataset as well ( Supplementary Fig.  2e-f) .
The results suggest that MetaCyto is able to merge small clusters in a biologically meaningful way, preventing over-partitioning of the cell subsets, thus allowing the clustering analysis to be performed without tuning any parameters.
Meta-analysis using MetaCyto confirms previous findings
After evaluating the performance of MetaCyto in analyzing cytometry data from single studies, we next tested the ability of MetaCyto in yielding consistent results from combining multiple studies. We applied MetaCyto to identify cell types whose frequencies are different between age, gender and race groups. We downloaded 10 studies from ImmPort containing cytometry data. These 10 studies had been contributed from four different institutions, where 86 panels containing 74 different markers were used ( Fig. 3 and  Supplementary Table 3) . Altogether, the datasets contain 2926 whole blood or PBMC samples from 984 healthy subjects and were acquired using either flow cytometry or CyTOF. The subjects are proportionately distributed by gender, with slightly more female than male. The age span range from 19 to 90 years. The subjects come from five different defined racial groups. Among them, over 90% were White or Asian (Supplementary Fig. 3 ).
We used both unsupervised and guided MetaCyto analysis pipelines in parallel to identify cell subsets. For the latter, we used 23 cell type definitions from the Human ImmunoPhenotyping Consortium (HIPC) 29 , ranging from effector memory T cells to monocytes (Supplementary Table 4) . We then estimated the effect size of age, gender and race on the cell type proportions using hierarchical statistical models.
To see if the results from MetaCyto were consistent across studies, we performed leave-one-out analysis ten times. Each time, we left one of the 10 studies out and estimated the effect sizes of age, gender and race using the rest nine studies. We found that the leaveone-out analysis agree well with the full meta-analysis (correlation ranges from 0.76 to 1, Supplementary Table 5) .
We then validated our results using the effect sizes of age and gender, previously well characterized in other studies 20, 30 . We tested whether results obtained with MetaCyto could replicate results from a previous independent study (Carr et al. 30 ). Among the 23 cell types identified by the guided analysis pipeline, 14 overlapped with the cell types included in the Carr study. We compared the effect size of age and gender on the proportion of these 14 cell types, between MetaCyto on the 10 studies, and the independent results from Carr, et al. We found that results agree well with each other on both the effect size of age (r = 0.69, p = 0.006, Fig. 4a ) and gender (r = 0.71, p = 0.004, Fig. 4b ).
The only discrepancy between our analysis and Carr study was the effect of age on CD8+ T cells (Fig. 4a) . Our result showed that the proportion of CD8+ T cells significantly decreases with age, while Carr study reported an increase with age. We visually inspected MetaCyto's auto-gating, and ruled out such disagreement being caused by gating errors in our study (Fig. 4c) . The forest plot showed that our finding was consistent across cytometry panels (Fig. 4d) . In the literature, one study found that CD8+ T cell proportion decrease with age 31 while another study found no association between CD8+ T cells and age 32 . These discrepancies suggest that the effect of age on CD8+ T cells is highly variable and environment specific factors might be contributing to these results. Future studies are needed to identify the exact factors.
Meta-analysis using MetaCyto identifies novel racial differences in immune cells
Our meta-analysis using the guided pipeline in MetaCyto revealed five cell types to be significantly different between the Asian and White. Asians have higher percentages of total CD4+ T cells and CD4+ central memory T cells, and lower percentages of natural killer (NK) cells, naïve CD8+ T cells and total CD8+ T cells (Fig. 5a) . Among these findings, only the difference of total CD4+ T cells has been reported previously 33 . MetaCyto was able to identify this racial difference consistently across all cytometry panels (Fig. 5b) .
Combining the results from all panels allowed us to confirm the difference with high confidence (p = 1.2x10 -7 ).
To confirm the four novel racial differences, we inspected the results from MetaCyto in detail. First, we visualized the identified cell populations in all studies, and confirmed that our results were not artifacts of automated gating ( Fig. 5c and Supplementary Fig. 4a ).
We then tested if these racial differences were consistent across cytometry panels. Cochran's Q test did not identify significant heterogeneity between cytometry panels (p value ranges from 0.27 to 0.9). Visual inspection of the forest plots also confirmed that the results were consistent in most of the cytometry panels ( Fig. 5d and Supplementary Fig. 4b ).
Results from the unsupervised analysis identified multiple cell types, other than the 23 types used in the guided analysis, whose abundance were different between Asian and White (Supplementary Table 6 ). As one example, we found that the proportion of a subpopulation of CD8+ T cells, the CD3+ CD4-CD45RA+ CD8+ CD85J-cell population, is significantly higher in Asians than in Whites (Supplementary Fig. 5 ). A closer look at the forest plot revealed that the association between this population and race was not at a significant level in most studies taken independently. However, by combining the results from multiple studies, we were able to identify this association with high confidence (p=0.0049).
DISCUSSION
With the collection of publically available cytometry studies rapidly growing, researchers can often identify multiple studies that were designed or can be re-purposed to answer a common research question. Meta-analysis of these studies allows researchers to answer the research question with a more robust conclusion and higher statistical power. Many cytometry studies that are publically available include hundreds of high dimensional cytometry data.
Performing meta-analysis manually on these studies is not only time consuming, but also prone to human error and bias. In this study, we developed and demonstrated a computational tool called MetaCyto, which allows fully automated meta-analysis of both CyTOF and flow cytometry data.
When performing a meta-analysis of cytometry data, a big challenge lies in the identification of common cell subsets across heterogeneous cytometry studies. In MetaCyto, we implemented two complementary analysis pipelines to automate the cell identification process. The guided analysis pipeline is able to identify cell populations using user-defined cell definitions. For example, regulatory T cells can easily be identified using the definition "CD3+ CD4+ Foxp3+". Such an approach allows researchers to incorporate their domain knowledge into the analysis, making the result more biologically relevant. In addition to the guided analysis pipeline, MetaCyto also allows researchers to identify cell populations in an un-supervised manor. Due to the high dimensionality of cytometry data, an exhaustive grid search will lead to an astronomical number of cell subsets. For example, if we divide each marker into positive and negative regions, 45 markers in a CyTOF experiment have 2 45 combinations. To avoid such a situation, the unsupervised pipeline in MetaCyto first identifies cell clusters using a clustering method. Successful efforts were made by the community to develop efficient clustering methods for flow cytometry data analysis. We built MetaCyto to be fully compatible with existing clustering methods.
MetaCyto is able to merge and transform the clusters from existing clustering algorithms in a biologically meaningful way, therefore improving result quality and enabling further meta-analysis of many studies.
Based on the test result, we recommend over-clustering the data first, followed by the merging of the clusters by MetaCyto. Such a strategy not only makes the method tuning free, but also is more computationally efficient than traditional auto-tuning methods, which require running the clustering algorithm multiple times with different parameters.
In MetaCyto, the distribution of each marker is bisected into positive and negative regions using a silhouette-scanning method. However, some markers may show tri-modal distributions. Although the silhouette-scanning method can easily be modified to divide the distribution into three regions (low-medium-high), only bisection is used in MetaCyto for the following reasons. First, it is known that multiple technical factors, such as auto-fluorescence, compensation, transformation and non-specific binding of antibodies, can lead to false tri-modal distributions 34, 35 . In these cases, the low-medium-high regions do not represent distinct cell populations. Second, upon examining multiple cytometry studies, we found that although some markers (e.g. CD8, CD45RA, CD127) show tri-modal distributions in certain cytometry studies, they show bi-model distributions in other studies. Such inconsistency makes it difficult to reliably relate cell subsets across studies. Finally, our test result shows that bisection using silhouette scanning is able to identify the population that is truly positive for a marker even when the distribution is not bi-modal.
There are several potential limitations of the current study. In the unsupervised analysis pipeline of MetaCyto, although the merging step makes the clustering result more robust, it may eliminate some small cell populations of biological meaning. To overcome this limitation, researchers can use a more sensitive method, such as CITRUS 13 , to identify the cell subsets of interest from a single study. They can then craft cell definitions for those subsets and use the guided analysis pipeline of MetaCyto to perform meta-analysis across studies. Another limitation is that our meta-analysis only established correlations between cell populations and race. In-depth studies are needed to further validate our findings and to identify the genetic or environmental causes of these differences. each fcs file. All data from ImmPort were arcsinh transformed. For flow cytometry data, the formula f(x) = arcsinh (x/150) was used. For CyTOF data, the formula f(x) = arcsinh (x/8) was used. All transformation and compensation were done using the preprocessing or preprocessing.batch function in MetaCyto.
Cytometry data FlowCAP WNV was transformed and subset to only include protein markers. The pre-processing was doing using the same code provided by the Weber study 15 : github.com/lmweber/cytometry-clustering-comparison
Evaluating the performance of bisection algorithm
In Supplementary Fig. 1 , Different Methods were tested to bisect the distribution of each marker.
Silhouette scanning method: The range of a marker was divided into 100 intervals using 99 breaks. The distribution was bisected at each break and the corresponding average silhouette 26 was calculated. The break giving rise to the largest average silhouette was used as the cutoff for bisection.
K-means method: based on the values of a single marker, cells were clustered into 2 groups using k means clustering algorithm where k = 2. The cutoff value for bisection was the border between the 2 groups.
Hierarchical clustering method: based on the values of a single marker, cells were grouped into a Hierarchical tree. The tree was then cut into 2 groups at the top level. The cutoff value for bisection was the border between the 2 groups.
First valley method: The distribution of each marker was smoothed using the smooth.spline function. The peaks in the distribution were identified using the .getPeaks function in flowDensity package 27 . The lowest points between peaks were defined as valleys. The valley with the smallest marker value was used as the cutoff for bisection.
Last valley method: The valley with the largest marker value was used as the cutoff for bisection.
Median valley method: The valley closest to the median of the marker value was used as the cutoff for bisection.
Mean method: The mean of the marker distribution was used as the cutoff.
Median method: the median of the marker value was used as the cutoff Middle method: the mean of the max and min of the marker values were used as the cutoff.
After markers in SDY420 data were bisected, cells fulfilling the requirement of each cell definition (listed in Supplementary Table 1) were identified. For example, for cell definition "CD3+ CD8+ CD4-", cells falling into the CD3+ region were identified. Similarly, cells falling into CD8+ and CD4-regions were identified. The intersection of the 3 sets of cells was the cells corresponding to the cell definition "CD3+ CD8+ CD4-". The proportion of cells corresponding to each cell definition was calculated and compared to the proportion provided by the author. The Spearman correlation was used as a measurement of the bisection algorithm.
Identifying cell subsets with the guided analysis pipeline in MetaCyto
Cell definitions were created based on the gating strategies provided by authors of SDY 420 and SDY478 from ImmPort database or based on the cell definition from the Human ImmunoPhenotyping Consortium 29 . The cell definitions are available in the supplementary table 1, 2 and 4.
To identify the corresponding cell subsets, Silhouette scanning was used to bisect the distribution of cell markers into positive and negative regions. Cells fulfilling the cell definitions were then identified. For example, the CD3+ CD4+ CD8-(CD4+ T cells) cell subset corresponds to the cells that fall into the CD3+ region, CD4+ region and CD8-region concurrently. The proportion of each cell subset in blood was calculated by dividing the number of cells in the subset by the total number of cells in the blood. The procedure is performed using the searchCluster or searchClster.batch function in the Metacyto package.
Identifying cell subsets with the un-supervised analysis pipeline in MetaCyto
FlowSOM 11 or FlowMeans 12 were used to identify cell clusters in the cytometry data. Silhouette scanning was used to identify a threshold that bisects the distribution of cell markers into positive and negative regions. To label the identified cell clusters, the marker levels in each cluster were compared with the bisection threshold. If the marker levels of 95% of cells in the cluster are above or below the threshold, the cluster will be labeled as positive or negative for the marker, respectively. Otherwise, the cluster will not be labeled for the marker. If a marker is positive or negative in 95% of all cells, the marker is not used to label any clusters. The procedure is performed using the labelCluster function in MetaCyto.
The generated labels were then used to identify the corresponding cell subsets, in a fashion similar to the guided analysis pipeline. Notice that such a process is equivalent of merging cell clusters that have the same labels into a hyper-rectangle shaped cluster. The proportion of each cell subset in blood was calculated by dividing the number of cells in the subset by the total number of cells in the blood. The procedure was performed using the searchCluster or searchClster.batch function in the Metacyto package.
For MetaCyto, the proportion of each cell subset in blood was estimated by the guided analysis pipeline described above.
For flowDensity, the flowDensity function was used to identify the cell subsets corresponding to the cell definitions. The proportion of each cell subset in blood was calculated by dividing the number of cells in the subset by the total number of cells in the blood.
For ACDC, the cell definitions were first turned into a cell type-marker table with entries of 1, -1, and 0 representing a marker is present, absent, and ignored in a cell type respectively. The landmark points of each cell type were generated by clustering samples within each partition defined by the cell type-marker All three methods received the same types of input: preprocessed CyTOF data and the cell definitions. No additional information or human input was provided to help identifying cell subsets. The Spearman correlation coefficient between author's result and MetaCyto or flowDensity or ACDC result was calculated to measure the performance. population in the manual gating result and each cell population in the auto-gating result, a 2 × 2 contingency table was calculated containing the false positive (FP), true positive (TP), false negative (FN) and true negative (TN). The recall (Re) was calculated as TP/(TP + FN), the precision (Pr) was calculated a TP/(TP + FP). The F measure was calculated as F = (2 × Pr × Re)/(Pr + Re). For each population in manual gating result, the best F measure and its corresponding recall and precision were used as the F measure of the population. The overall F measure, Recall and Precision were the average of F measure, Recall and Precision of all manual gated populations, weighted by the size of each manual population.
Estimating the proportions of cell subsets using data from Carr study The cell gating results from Carr study, in the form of proportions of parents gate, are available as Supplementary Data Set 1 of the Carr study pulication 30 . The proportion of a cell subset within blood is calculated by multiplying the proportions of parents in all gating steps together. For example, the proportion of CD4 T cell in blood is calculated by multiplying the proportion of total T cells in blood by the proportion of CD4 T cells in total T cells.
Statistical Analysis
2-level hieratical regression models were used in the meta-analysis of the 10 human immunology studies from ImmPort: the proportion of cell subsets was regressed against age, gender and race (Y ~ age + gender + race) in each cytometry panel. The effect size was defined as the regression coefficient divided by the standard deviation of Y. The overall effect size from all cytometry panels was estimated using a random effect model. For data from the Carr study, the proportion of a cell population was regressed against age and gender. Race information was missing in the data, therefore was omitted in the regression. All statistical analysis was performed using the metaAnalysis function in MetaCtyo. The p-value was adjusted using the Benjamini-Hochberg 37 correction.
To test the heterogeneity in Meta-analysis, Cochran's Q test was performed using the cochran.Q function in the Mada package.
In Fig. 4 a and b , Pearson correlations are calculated and tested against the null hypothesis (correlation equals zero) using the cor.test function in R.
In Fig. 5e and Supplementary Fig. 5b , Shapiro-Wilk test was performed to check the normality assumption using the shapiro.test function in R. F test was performed to check the equal variance assumption using the var.test function in R. A two-sided unpaired Mann-Whitney test is performed to test the difference between two groups using the wilcox.test function in R.
Code availability
The MetaCyto R package is available on GitHub:
The source code to reproduce results in . The p value in a is calculated using a random effect model, adjusted using Benjamini-Hochberg correction. p value in b is calculated from unpaired Mann-Whitney test without correction. See Supplementary Table 6 for a complete list of differences in immune cells between races identified by the unsupervised pipeline.
Supplementary Table 1 : A list of cell definitions used to identify the 24 cell populations in cytometry data (SDY420) from ImmPort. The cell definitions are created based on the author's gating strategy provided in SDY420.
Supplementary Table 2 : A list of cell definitions used to identify the 88 cell populations in cytometry data (SDY478) from ImmPort. The cell definitions are created based on the author's gating strategy provided in SDY478.
Supplementary Table 3 : A summary of 10 studies included in the meta-analysis.
Supplementary Table 4 : A list of cell definitions used to identify the 23 cell populations in all 10 studies included in the meta-analysis. Figure 3: Data from 10 human immunology studies includes highly heterogeneous cytometry panels. Eighty-six panels with diverse sets of markers were used in these 10 studies, with the panels represented vertically. The specific markers used are represented horizontally. A red square in each grid element indicates that particular marker was used in a panel. MetaCyto Guided Analysis Pipeline Pearson: 0.98 CCR7  CD127  CD14  CD16  CD161  CD19  CD20  CD24  CD25  CD27  CD28  CD3  CD33  CD38  CD4  CD45RA  CD56  CD8  CD85J  CD94  HLADR   IGD  TCRGD  CD4/CD20  PSTAT1  PSTAT3  PSTAT5  IL2/IFNPE  CD138  CD45  CD11B  CD15  CD40  CD62L  CD86  CCR6  CXCR3  CXCR5  ICOS  BDCA2  BDCA3  CD123  CD1C  CD2  LIN−2  CD3−19−20−56   SLAN  CXC35  CD3−19−20−15   NKG2D  NKP44  CTLA4  FOXP3  BDCA1  LIN−1  CD11C  CCR4  BCL2  GRANB  K167  CD314  CD16/56   PD1  STAT1  STAT3  STAT5  CD57  CD3/CD14  CD4/CD19   CD66B  CD14/CD3   CD11A  CD95  KI67   SDY112 
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